Drugs / SZ011 CAR-NK
last change Dec 2025 re-read 3 minutes ago

SZ011 CAR-NK

Cell therapy

Developed for
malignant epithelial tumor of ovary
Investigated by
Guangdong ProCapZoom Biosciences Co., Ltd. · Shantou University Medical College

Trials 1

20252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 0 NCT05856643 Aug 2024 → Jun 2025 overdue malignant epithelial tumor of ovary Shantou University Medical College Recruiting No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as SZ011 CAR-NK ClinicalTrials.gov intervention name — accepted as the source's own label NCT05856643 ↗
Modality Cell therapy “Drug: SZ011 CAR-NK” NCT05856643 ↗